A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer
This survey study is looking to determine if patient reported outcomes(using the PROMIS survey) will vary according to the presence of recurrent or metastatic lung or esophageal cancer.
Checked against the public recordLast updated Oct 26, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Virginia
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * ≥18 years of age * Suspected or Known diagnosis of lung or esophageal cancer * Willing and able to complete questionnaires Exclusion Criteria: * Subjects unwilling to provide informed consent * Subjects unwilling or unable to answer the questionnaires
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of VirginiaCharlottesville, Virginia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 26, 2018. Always confirm current availability with the study team.